title: High-dose intravenous immunoglobulin does not reduce the numbers of circulating CD14(+)CD16(++) monocytes in patients with inflammatory disorders.
authors.forename: Angela S W
authors.initials: AS
authors.lastname: Tjon
authors.forename: Herold J
authors.initials: HJ
authors.lastname: Metselaar
authors.forename: Peter A W
authors.initials: PA
authors.lastname: te Boekhorst
authors.forename: P Martin
authors.initials: PM
authors.lastname: van Hagen
authors.forename: Jaap
authors.initials: J
authors.lastname: Kwekkeboom
mesh_terms: D017074:Common Variable Immunodeficiency / Q000628:therapy*; D005260:Female; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000494:pharmacology*; D018950:Lipopolysaccharide Receptors / Q000378:metabolism*; D008297:Male; D009000:Monocytes / Q000187:drug effects*; D017452:Receptors, IgG / Q000378:metabolism*
chemical_list: D016756:Immunoglobulins, Intravenous; D018950:Lipopolysaccharide Receptors; D017452:Receptors, IgG